| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director | CFO And Chief Business Officer +1 more
4 companies
Gengos Andrew is a Chief Financial Officer at Terns Pharmaceuticals, Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 15 buys and 2 sells.
Estimated insider holdings value: $5.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2025 | TERN Terns Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 10,000 | $3.93 | $39,283.00 | +28.6% | +94.3% | - | |
| Jun 16, 2025 | TERN Terns Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 15,000 | $3.81 | $57,082.50 | +100.0% | +77.8% | - | |
| Sep 5, 2024 | CFO And Chief Business Officer | Sell | 1,272 | $0.57 | $719.95 | -1.3% | - | - | ||
| Jun 7, 2023 | See Below | Buy | 15,000 | $3.43 | $51,445.01 | +7.5% | - | - | ||
| Jun 5, 2023 | See Below | Buy | 65,012 | $2.95 | $191,572.21 | +35.8% | - | - | ||
| Jan 5, 2023 | See Below | Sell | 1,208 | $2.91 | $3,515.28 | -1.4% | - | - |